Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period

International Journal of Antimicrobial Agents

Volumn 21, Issue 6, 2003, Pages 542-546

  Pantazatou, Angeliki ^a   Papaparaskevas, Joseph ^a   Stefanou, Ioanna ^a   Papanicolas, John ^a   Demertzi, Elli ^a   Avlamis, Athina ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Epidemiology; Gentamicin; Greece; Methicillin resistance; Phenotypes; Staphylococcus aureus; Vancomycin

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; METICILLIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; EPIDEMIOLOGICAL DATA; GREECE; HEALTH CARE FACILITY; HOSPITAL; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0037507253     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(03)00055-4     Document Type: Article

References (25)

1. Ayliffe G.A. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24:(Suppl. 1):1997;S74-S79.
2. Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J. Antimicrob. Chemother. 44:(Suppl. A):1999;1-9.
3. Lelievre H., Lina G., Jones M.E., et al. Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics. J. Clin. Microbiol. 37:1999;3452-3457.
4. Witte W., Braulke C., Cunny C., Heuck D., Kresken M. Changing pattern of antibiotic resistance in methicilin-resistant Staphylococcus aureus from German hospitals. Infect. Control. Hosp. Epidemiol. 22:2001;683-686.
5. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., Tenover F.C. Methicillin-resistant Staphylococcus aureus strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:1997;135-136.
6. Sievert D.M., Boulton M.L., Stoltman G., et al. Staphylococcus aureus resistant to vancomycin - United States 2002. MMWR Morb. Mortal. Wkly. Rep. 51:2002;565-567.
7. Vatopoulos A.C., Kalapothaki V., Legakis N.J. An electronic network for the surveillance of antimicrobial resistance in bacterial nosocomial isolates in Greece. The Greek Network for the Surveillance of Antimicrobial Resistance. Bull. WHO. 77:1999;595-601.
8. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Testing. Documents M2-A6. Wayne, PA: NCCLS, 1997.
9. Hiramatsu K., Aritaka N., Hanaki H., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 350:1997;1670-1673.
10. Walsh T.R., Bolmstrom A., Qwarnstrom A., et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2001;2439-2444.
11. Voss A., Doebbeling B.N. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents. 5:1995;101-106.
12. Bell J.M., Turnidge J.D. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program 1998-1999. Antimicrob. Agents Chemother. 46:2002;879-881.
13. Kosmidis J., Polychronopoulou-Karakatsanis C., Milona-Petropoulou D., Mavrogenis N., Xenaki-Kondyli M., Gargalianos P. Staphylococcal infections in hospitals: the Greek experience. J. Hosp. Infect. 11:(Suppl. A):1988;109-115.
14. Katzanou M., Tassios P.T., Tseleni-Kotsovili A., Maniatis A.N., Vatopoulos A.C., Legakis N.J. A multi-centre study of nosocomial methicillin-resistant Staphylococcus aureus in Greece. Int. J. Antimicrob. Agents. 12:1999;1115-1119.
15. Torvaldsen V., Roberts C., Riley T. The continuing evolution of methicillin-resistant Staphylococcus aureus in Western Australia. Infect. Control. Hosp. Epidemiol. 20:1999;133-135.
16. Polyzou A., Slavakis A., Pournaras S., Maniatis A.N., Sofianou D., Tsakris A. Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-β-lactam antibiotics in a Greek hospital. J. Antimicrob. Chemother. 48:2001;231-234.
17. Tenover F.C., Lancaster M.V., Hill B.C., et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1998;1020-1027.
18. Wootton M., Howe R.A., Hillman R., Walsh T.R., Bennet P.M., MacGowan A.P. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:2001;399-403.
19. Hiramatsu K., Cui L., Kuroda M., Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 9:2001;486-493.
20. Tenover F.C., Biddle J.W., Lancaster M.V. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7:2001;327-332.
21. Sugino Y., Iinuma Y., Ichiyama S., et al. In vivo development of decreased susceptibility to vancomycin in clinical isolates of methicillin-resistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 38:2000;159-167.
22. Guerin F., Buu-Hoi A., Mainardi J.L., et al. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J. Clin. Microbiol. 38:2000;2985-2988.
23. Kantzanou M., Tassios P.T., Tseleni-Kotsovili A., Legakis N.J., Vatopoulos A.C. Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 43:1999;729-731.
24. Ike Y., Arakawa Y., Ma X., et al. Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J. Clin. Microbiol. 39:2001;4445-4451.
25. Hubert S.K., Mohammed J.M., Fridkin S.K., Gaynes R.P., McGowan Jr J.E., Tenover F.C. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected US hospitals. J. Clin. Microbiol. 37:1999;3590-3593.